These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35764242)

  • 41. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.
    Ye J; Hou B; Chen F; Zhang S; Xiong M; Li T; Xu Y; Xu Z; Yu H
    Acta Pharm Sin B; 2022 Jun; 12(6):2695-2709. PubMed ID: 35755274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel ROS-activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone.
    Zhang H; Chen W; Wang J; Du W; Wang B; Song L; Hu Y; Ma X
    Biomaterials; 2023 Feb; 293():121954. PubMed ID: 36538847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
    Zang X; Song J; Yi X; Piyu J
    J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glutathione-Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy.
    Zhang L; Zhu L; Tang L; Xie J; Gao Y; Yu C; Shang K; Han H; Liu C; Lu Y
    Adv Sci (Weinh); 2023 Jan; 10(3):e2205246. PubMed ID: 36442854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatment.
    Nguyen-Trinh QN; Trinh KXT; Trinh NT; Vo VT; Li N; Nagasaki Y; Vong LB
    Acta Biomater; 2022 Apr; 143():459-470. PubMed ID: 35235866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trident Molecule with Nanobrush-Nanoparticle-Nanofiber Transition Property Spatially Suppresses Tumor Metastasis.
    Gao G; Jiang YW; Zhan W; Liu X; Tang R; Sun X; Deng Y; Xu L; Liang G
    J Am Chem Soc; 2022 Jul; 144(26):11897-11910. PubMed ID: 35731698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
    Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
    Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acid-activatable oxidative stress-inducing polysaccharide nanoparticles for anticancer therapy.
    Yoo W; Yoo D; Hong E; Jung E; Go Y; Singh SVB; Khang G; Lee D
    J Control Release; 2018 Jan; 269():235-244. PubMed ID: 29146242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
    Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
    Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death.
    Moon Y; Shim MK; Choi J; Yang S; Kim J; Yun WS; Cho H; Park JY; Kim Y; Seong JK; Kim K
    Theranostics; 2022; 12(5):1999-2014. PubMed ID: 35265195
    [No Abstract]   [Full Text] [Related]  

  • 54. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90.
    Pan W; Cui B; Wang K; Shi M; Lu F; Li N; Tang B
    Theranostics; 2021; 11(16):7869-7878. PubMed ID: 34335969
    [No Abstract]   [Full Text] [Related]  

  • 55. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
    Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
    J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
    Liang B; Zhou D
    Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-Activating Therapeutic Nanoparticle: A Targeted Tumor Therapy Using Reactive Oxygen Species Self-Generation and Switch-on Drug Release.
    Kang RH; Kim Y; Kim JH; Kim NH; Ko HM; Lee SH; Shim I; Kim JS; Jang HJ; Kim D
    ACS Appl Mater Interfaces; 2021 Jul; 13(26):30359-30372. PubMed ID: 34142813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer.
    Zhu Q; Sun F; Li T; Zhou M; Ye J; Ji A; Wang H; Ding C; Chen H; Xu Z; Yu H
    Small; 2021 Apr; 17(13):e2007882. PubMed ID: 33690984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin-Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery.
    Xu B; Yan M; Zhou F; Cai D; Guo W; Jia X; Liu R; Ma T; Li T; Gao F; Wang P; Lei H
    Int J Nanomedicine; 2021; 16():7959-7974. PubMed ID: 34887660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG; Choi YH; Hyun JW; Kim GY
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.